Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
|
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [41] Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021
    Plumb, Ian D.
    Fette, Lida M.
    Tjaden, Ashley H.
    Feldstein, Leora
    Saydah, Sharon
    Ahmed, Amina
    Link-Gelles, Ruth
    Wierzba, Thomas F.
    Berry, Andrea A.
    Friedman-Klabanoff, DeAnna
    Larsen, Moira P.
    Runyon, Michael S.
    Ward, Lori M.
    Santos, Roberto P.
    Ward, Johnathan
    Weintraub, William S.
    Edelstein, Sharon
    Uschner, Diane
    VACCINE, 2023, 41 (15) : 2596 - 2604
  • [42] The Effectiveness of mRNA COVID-19 Vaccine Against SARS-CoV-2 Infection in Hemodialysis Patients: A Case-Control Study
    Hamad, Abdullah I.
    Elshirbeny, Mostafa
    Ali, Mohamed Y.
    Ghonimi, Tarek A.
    Ibrahim, Rania A.
    Yasin, Fadumo Y.
    Singh, Poonam R.
    Aly, Sahar
    Abuhelaiqa, Essa
    Al-Malki, Hassan A.
    Alkadi, Mohamad M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 318 - 318
  • [43] Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
    Lirong Cao
    Jingzhi Lou
    See Yeung Chan
    Hong Zheng
    Caiqi Liu
    Shi Zhao
    Qi Li
    Chris Ka Pun Mok
    Renee Wan Yi Chan
    Marc Ka Chun Chong
    William Ka Kei Wu
    Zigui Chen
    Eliza Lai Yi Wong
    Paul Kay Sheung Chan
    Benny Chung Ying Zee
    Eng Kiong Yeoh
    Maggie Haitian Wang
    Nature Medicine, 2022, 28 : 1715 - 1722
  • [44] Letter to the editor: More data on vaccine efficacy/effectiveness of COVID-19 vaccines against asymptomatic SARS-CoV-2 infection
    Chen, Ying-Wen
    Ko, Wen-Chien
    EUROSURVEILLANCE, 2021, 26 (35)
  • [45] SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
    Ssentongo, Paddy
    Ssentongo, Anna E.
    Voleti, Navya
    Groff, Destin
    Sun, Ashley
    Ba, Djibril M.
    Nunez, Jonathan
    Parent, Leslie J.
    Chinchilli, Vernon M.
    Paules, Catharine, I
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [46] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    VACCINES, 2021, 9 (03) : 1 - 13
  • [47] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 359 - 371
  • [48] Epidemiology of SARS-CoV-2 infection and COVID-19
    Salzberger, B.
    Buder, F.
    Lampl, B.
    Ehrenstein, B.
    Hitzenbichler, F.
    Hanses, F.
    INTERNIST, 2020, 61 (08): : 782 - 788
  • [49] Infection with SARS-CoV-2 is not the same as covid-19
    Bamji, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [50] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2025, 51 (01) : 139 - 156
12345